Loading
Latest filing published 08 Sept 2023 for Arch Therapeutics, Inc., €1,740.
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
All filings by Terrence W. Norchi on record concern Arch Therapeutics, Inc. The record holds 6 filings, for trades running from 26 June 2013 to 31 August 2023.
Every open-market trade on record is a purchase: 1 purchase worth €1,740, and no sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 4 share grants. In 2023 alone, the filings show 1 purchase and no sales.
The latest filing, published on 8 September 2023, reports an open-market purchase of €1,740 in Arch Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations